NEW YORK (GenomeWeb News) — Molecular Devices today said fourth-quarter revenues remained virtually flat as R&D spending was unchanged and profit decreased 31 percent.
Total receipts for the three months ended Dec. 31, 2006, increased to $52.8 million from $52.7 million year over year.
Molecular Devices did not break out revenues by business unit.
R&D spending was flat at $6.3 million in both quarters.
The company said profit declined to $4 million from $5.8 million in the year-ago period.
Molecular Devices said it had around $22.8 million in cash and equivalents as of Dec. 31.
Last week MDS said it plans to acquire Molecular Devices for $615 million in cash.